F8 and hemophilia A: However, recurrent exposure to FVIII can lead to the development of inhibitors (neutralizing antibodies to FVIII), with 20-30% of patients with severe and 5% of patients with mild to moderate hemophilia A producing inhibitors within the first 50 exposure days to FVIII (1, 2).